'Heart protection study' diaporamas de présentation

Critical appraisal of clinical research evidence

1.31k views • 121 slides

Ste nts Are Not Enough: Statins

Ste nts Are Not Enough: Statins. Keith Channon. Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford. 5.07 mm 2. 5.18 mm 2. Plaque Remodelling in Angiographically Normal Artery Preservation of Lumen Area. Stable Plaque. Unstable Plaque

612 views • 39 slides

Emerging targets in HDL modification: Relevant data from development programs

Emerging targets in HDL modification: Relevant data from development programs. Prof. John Kastelein Academic Medical Centre Amsterdam, The Netherlands. Novel Approaches to Modify Lipids and Lipoproteins. Low Density Lipoprotein High Density Lipoprotein Triglyceride Rich Lipoproteins

473 views • 38 slides

The future of HDL raising

The future of HDL raising. By Ashraf Reda M.D. Minoufiya University President of: WGLVR. 1. Peripheral Tissue. Blood Excess cholesterol. Liver. Bile. HDL:. Reverse cholesterol transport. 6. Ashraf Reda,M.D . Reverse cholesterol transport and HDL metabolism. Bile. FC. A-1. A-1.

535 views • 25 slides

Search strategy and results

Search strategy and results. Amir Kashani, et al. Circulation. 2006;114:2788-2797. Baseline Characteristics. CHD indicates coronary heart disease; DM, diabetes mellitus; PMSG, Pravastatin Multinational Study Group; SSSS, Scandinavian Simvastatin Survival Study; HPS,

140 views • 6 slides